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Utilizing multiple tracking techniques, track the velocity, strain and stain rate of ca-
rotid. The mechanical parameters which were used for statistical analysis at different
points of carotid intima were measured simultaneously and calculated automatically at
different time of before and after treatment of rosuvastatin for 6 months were
compared and studied.
Results: The level of IMT after treatment of rosuvastatin was lower than that before
treatment (P<0.05), the systolic maximum velocity and strain rate after treatment of
rosuvastatin in carotid atherosclerosis plaque were lower signiﬁcantly than those
before treatment of rosuvastatin (all P<0.01).
Conclusions: MTT technique could early quantitatively evaluate the effect of rosu-
vastatin on the elasticity degree of blood vessel wall, artherosclerosis and the mech-
anism asynchrony of the plaque intima. So, rosuvastatin therapy in Patients with
Metabolic Syndrome could not only effectively prevent artherosclerosis, but also
reduce the damage of target organ at the same time, which have a signiﬁcant effect to
early protect the cardiovascular system.GW25-e0441
Impact of endogenous oestrogens on the risk of no-reﬂow in postmenopausal
women with ST-elevation acute myocardial infarction
Dong Mei, Yang Jun
Yantai Yuhuangding Hospital
Objectives: There is evidence that sex hormones, particularly estrogens, regulate
inﬂammation, a process integral to myocardial no-reﬂow. Thus, we prospectively
assessed the effects of endogenous estrogen on the risk of myocardial no-reﬂow in
postmenopausal women with ST-elevation myocardial infarction (STEMI).
Methods: Consecutive 100 postmenopausal women, diagnosed with STEMI and
undergoing emergence percutaneous coronary intervention (PCI) were included in
this study. Blood samples were obtained before PCI and assayed for endogenous
sex hormones. Logistic regression models were developed with adjustment for
confounders.
Results: Compared with normal reﬂow group, the circulating levels of estrone,
estradiol, sex hormone binding globulin (SHBG) and Hypersensitive C-reaction
protein (Hs-CRP) were signiﬁcantly higher in no-reﬂow group (P<0.05). The per-
centage of diabetes mellitus was higher in the no-reﬂow group compared with normal
reﬂow group (47.8% versus 24.7%, respectively; P¼0.034). In univariable logistic
regression models, diabetes mellitus, lesion length, reference luminal diameter,
thrombus score4 and the levels of estrone, estradiol and SHBG were all found to be
positively associated with the risk of no-reﬂow (P<0.05). After adjusting for these
factors, diabetes mellitus (OR¼9.764, CI 4.888-192.631; P¼0.025), thrombus
score4 (OR¼5.547, CI2.247-12.510; P¼0.042) and estradiol levels (OR 4.647, CI
1.148-10.238; P¼0.043) continued to demonstrate strong positive associations with
the risk of no-reﬂow.
Conclusions: Our data showed that high circulating levels of endogenous estrogens
have a positive and statistically signiﬁcant relationship with no-reﬂow in post-
menopausal women with STEMI. It suggested that estrogens had a potential detri-
mental effect on myocardial no-reﬂow.GW25-e1555
The Risk Factors of Malignant Ventricular Arrhythmia in the early stages of
elderly Patients with Acute Myocardial Infarction
Yang Chengming, Lin De-Sheng, Fan Jun, Ran Xi, Zeng Chun-Yu, Cheng Qiao,
Zhang Xiao-Qun
Department of Cardiology, Daping Hospital, The Third Military Medical University,
Chongqing 400042, China
Objectives: To invetigate the incidence, mortality and risk factors of malignant
ventricular arrhythmia in the early stages of elderly patients with acute myocardial
infarction.
Methods: A retrospecttive study was conducted on 420 elderly patients with acute
myocardial infarction from January 2009 to June 2013. According to the Holter
outcomes, the patients were divided into two groups, malignant ventricular arrhythmia
(MVA) group and non-MAV group. Gender, age, history of diabetes, hypertension,
hyperlipidemia, old myocardial infarction and smoking, count of white blood cell,
hemoglobin, neutrophil, platelet, total cholesterol, low density lipoprotein, high
density lipoprotein, triglycerides, potassium, blood urea nitrogen, serum creatinine,
blood glucose, creatine kinase, creatine kinase MB, Troponin I, Killip class, corrected
Tpeak-Tend interval, heart rate variability, opening of infarct-related artery by direct
PCI, ultrasound results were recorded. Then the related factors were compared be-
tween the two groups and logistic regression analysis was applied to determine the risk
factors for MAV.
Results: Among the 420 patients, MVA occurred in 152 patients and 26 patients died
of MVA. Logistic regression analysis showed that advanced age, elevated creatine
kinase-MB and Troponin I, low blood potassium, higher Killip class of cardiac
function, reduced heart rate variability, not opening of infarct-related artery by direct
PCI, reduced LVEF were risk factors of MVA.
Conclusions: The incidence and mortality of MVA in elderly patients with acute
myocardial infarction was higher, more clinical attention should be paid to the elderly
patients who have the above risk factors.C132 JACC Vol 64/16/Suppl C j October 16–1GW25-e0235
Effects of Liraglutide on Glycemic Control and Left Ventricular Function in
Patients with Acute Myocardial Infarction: a Randomized, Double-blind,
Placebo-controlled Clinical Trial
Chen Weiren, Yun-Dai Chen
PLA General Hospital at Beijing, China
Objectives: Glucagon-like peptide-1 (GLP-1) is an incretin hormone that regulates
plasma glucose, and GLP-1 analogues were recently introduced for the treatment of
acute myocardial infarction (AMI).We planned to evaluate the effects of liraglutide on
left ventricular function in patients with AMI.
Methods: A total of 62 patients with AMI were enrolled in this study between
October 2013 and January 2014. Of these, 50 patients were randomized 1:1 to receive
either liraglutide or placebo for 7 days.
Results: At 7 days, the primary end point, the difference in the change in left ven-
tricular ejection fraction between the two groups was +5.5% (liraglutide vs. placebo
95% CI +1.3% to +11.2% P < 0.001). After 7 days of treatment, the fasting glucose
levels decreased signiﬁcantly greater in the liraglutide group (4.0  2.4 mmol/L),
compared with that in the control group (2.5  1.9 mmol/L, vs. liraglutide group
P¼0.01). The difference in decrease in serum high sensitivity C reactive protein levels
was 0.22 mg/dL (liraglutide vs. placebo 95% CI 0.42 to 0.02; P ¼ 0.002). The dif-
ference in rise in serum superoxide dismutase levels after 7 days of treatment was
+14.9 U/mL (liraglutide vs. placebo 95% CI +3.1 to +26.1; P < 0.001).
Conclusions: GLP1 could improve glucose metabolism and left ventricular function
in patients with AMI, making it a potential adjuvant therapy for AMI.
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Effect of different doses of rosuvastatin on serum concentrations of VCAM-1,
ICAM-1 and PAI-1 in the patients with acute coronary syndrome
Zhang Li-Zhen, Ma Xiu-Rui, Zhang Zhun-Lin, Zhu Li-Jun, Chen Jie
Shanxi Cardiovascular Hospital
Objectives: To explorer the effect of different doses of rosuvastatin on serum con-
centrations of vascular cell adhesion molecule-l (VCAM-1), intercellular adhesion
molecule-l (ICAM-1), plasminogen activator inhibitor-1 (PAI-1) in the patients with
acute coronary syndrome (ACS).
Methods: A total of 236 patients with acute coronary syndrome were randomly
divided into A group (128 patients were administrated to rosuvastain 10mg per day)
and B group (128 patients were administrated to rosuvastain 20mg per day). Another
50 agedmatched healthy subjects who were conﬁrmed no coronary artery stenosis by
coronary angiography were enrolled as control group.Serum samples of the patients in
both A and B group were collected in order to detect the level of VCAM-1, ICAM-1,
PAI-1 before the patients accept the treatment of rosuvastain. Moreover the serum
levels of VCAM-1, ICAM-1 and PAI-1 were measured 1 and 2 weeks after rosu-
vastain treatment by Enzyme Linked Immunosorbent Assay (ELISA).
Results: Compared with the control group, signiﬁcantly increasing of the serum
concentration of VCAM-1 (706.653.6ug/L vs. 56047.2ug/L, P<0.05), ICAM-1
(375.334.6ug/L vs. 27635.2ug/L, P<0.05) and PAI-1 (55.47.9ng/L vs.
42.38.1ng/L, P<0.05) were observed in patients with ACS. The serum levels of
VCAM-1, ICAM-1 and PAI-1 signiﬁcantly decreased from 711.554.6 to
623.758.9ug/L (p <0.05), 389.523.7 to 352.630.5ug/L (p <0.05) and 57.68.2
to 50.29.3ng/L (p <0.05) in the A group 1 week after the treatment of rosuvastain
and from 699.162.8 to 603.260.7 ug/L (p <0.05), 370.442.3 to 337.628.3 ug/L
(p<0.05) and 53.46.9 to 46.58.8 ng/L (p <0.05) in the B group 1 week after the
treatment of rosuvastain, respectively. 2 weeks after the treatment of rosuvastain, the
serum concentration of VCAM-1, ICAM-1, PAI-1 were decreased both in A and B
group (P<0.05). Whereas in the B group, the serum concentration of VCAM-1,
ICAM-1, PAI-1 were lower than that in the A group 2 weeks after the treatment of
rosuvastatin 51237.4 vs. 55642.2 ug/L (P<0.05), 24638.4 vs. 27134.6ug/L
and 38.68.3 vs. 43.87.6 ng/L (P<0.05), respectively.
Conclusions: Signiﬁcant decreases of VCAM-1, ICAM-1 and PAI-1 in the sera of
ACS patients were observed at both 1 and 2 weeks after treatment with rosuvastatin,
and signiﬁcantly greater reduction were observed with the dose of rosuvastatin
increasing.
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Association between the QRS complex duration on admission and the prognosis
of in-patient in people who suffered acute myocardial infarction
Bai Tao1, Wang Fan2
1The Cardiovascular Center, The First Hospital of Jilin University, 2The People’s
Hospital of Jilin Province
Objectives: To investigate the association between the QRS complex duration
(QRSd) on admission and the prognosis of in-patient in people who suffered acute
myocardial infarction.
Methods: In retrospective method, enroll patients of cardiovascular department of the
ﬁrst hospital attached to Jilin university from 01/01/2002 to 01/01/2008. All patients
suffered from acute ST segment elevation myocardial infarction (STEMI) and
excluded the following situations: 1) established stroke history; 2) completely atrial
ventricular block; 3) intraventricular aberrant conduction and other clinical situations9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
in which technicians can’t measure duration of QRS complex accurately, for example
early repolarization syndrome; 4) patients have already implanted pacemaker; 5) pa-
tients deny angiography; The total number is 88, of which 55 is male. According QRS
duration on admission, patients are divided into three groups. Group A: QRSd is
between 0.06s to 0.08 s; Group B: QRSd is between 0.08 s to 0.10 s; Group C:
QRSd>0.10 s; If QRSd is on the boundary, for example, one patient’s QRSd is 0.08 s,
he should be divided into Group B. All patients have been hospitalized within 12
hours after suffering acute myocardial infarction and received angiography. Observing
cardiovascular events happened in each group. Cardiovascular events are deﬁned as
serious arrhythmia, hypotension, cardiac failure, cardiac shock and sudden cardiac
death.
Results: The baselines-age, sex ratio, ratio of type 2 diabetes, smoking, hypertension,
hyperlipidemia, angina history, culprit artery and Killip’s classiﬁcation on hospital
admission in three groups have no signiﬁcant difference. In hospitalization, the usage
of aspirin, b-blockers, ACEI or ARB, diuretics, calcium channel blockers and cardiac
glycoside in different groups shows no differences. However, analyzing angiography
data, the average number of diseased artery show statistic difference. Comparing with
Group A, Group B and C show a tendency of more multivessel disease. The coronary
stenosis in Group B and C is also more severe than Group A. while comparing Group
B with Group C, there is no statistic difference. Incidence of cardiovascular events are
different in groups, Group B and C have more cardiovascular events than Group A,
while comparing Group B with Group C, there is no statistic difference.
Conclusions: In patients who suffered acute myocardial infarction,the QRSd has
prognostic value, even in normal range (0.08-0.12 s). The longer the QRS duration,
the worse the prognosis.
GW25-e2149
Impact of metabolic syndrome on acute myocardial infarction in economic aspect
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Zhong Ming1,3, Zhang Yun1,3, Zhang Wei1,3, Wang Zhihao1,4
1Key Laboratory of Cardiovascular Remodeling and Function Research Chinese
Ministry of Education and Chinese Ministry of Public Health, 2Shandong University
of Traditional Chinese Medicine, Ji’nan 250012, P.R. China, 3Department of
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Objectives: This study aimed to ﬁnd out the impact of metabolic syndrome (MS) in
patients with acute myocardial infarction (AMI) at hospital in economic aspect.
Methods: Patients with AMI at Qilu Hospital of Shandong University during January
2011 to May 2013 were divided into two groups using Chinese Diabetes Society
(CDS) criteria for MS. Comparison of medical costs, complication rate and cost-
effectiveness ratio (ICER) were analyzed.
Results: Compared with patients without MS (–MS), MS patients (+MS) had the
same hospital stays (12.135.94 vs. 11.866.16, P¼0.3588), total costs (47,
24030.18 vs. 48, 64033.02, P¼0.7654) and each day costs (4.815.11 vs.
5.035.08, P¼0.5405). Rate of acute heart failure (AHF, 7.76% vs. 7.93%,
P¼0.9211), atrial arrhythmia (6.27% vs. 7.67%, P¼0.3941), ventricular arrhythmia
(7.26% vs. 8.44%, P¼0.4979) and death (1.65% vs. 2.30%, P¼0.4668) had no sig-
niﬁcant difference between –MS and +MS groups. However, +MS had a lower event-
free rate compared with –MS (78.38% vs. 72.12%, 1.663% vs. 1.474% adjusted by
total costs, P¼0.0247). In cost-effectiveness analysis of percutaneous coronary
intervention (PCI), +MS had an increased incremental ICER for AHF (-3.72% vs.
-2.67%), atrial arrhythmia (-1.56% vs. -1.03%) and ventricular arrhythmia (-1.22% vs.
-0.95%), but a decreased ICER for event-free survival (2.96% vs. 2.04%).
Conclusions: MS has no impact on hospital stays and medical costs in patients with
AMI, but MS may reduce the complication-free rate and PCI cost-effectiveness.
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The Application of Intraaortic Balloon counterpulsation for Acute Myocardial
Infarction with Cardiogenic Shock
Wei Hongyan, Li Xin, Li Fang, Li Hengjie, Hu Chunlin, Liao Xiaoxing
the First Afﬁliated Hospital of Sun Yat-Sen University
Objectives: To observe the efﬁcacy and safty of emergency intra- aortic balloon
counterpulsation ( IABP) support in the patients with cardiogenic shock complicated
by acute myocardial infarction ( AMI).
Methods: In this retrospective study, 172 patients hospitalized in the ﬁrst afﬁliated
hospital of Sun-yat sen university from 2005.1to 2013.12, with cardiogenic shock
complicating acute myocardial infarction,intraaortic balloon counterpulsation (IABP
group, 87 patients) or no intraaortic balloon counterpulsation (control group, 85 pa-
tients). All patients were expected to undergo early revascularization (by means of
percutaneous coronary intervention or thrombolysis) and to receive the best available
medical therapy. Systolic blood pressure ( SBP), diastolic blood pressure ( DBP), heart
rate, Killip’ s grade was observed, and the primary end point of 30-day mortality,
complications including bleeding, ischemic complications, sepsis, and stroke were
assesmented.
Results: There were no signiﬁcant differences between two groups with regard to the
age, gender, time of pre- hospital, serum lactate levels, creatine level and Killip’s
grade, SBP, and DBP before IABP. The SBP, DBP and Killip’s grade after IABP in
the patients treated group were signiﬁcantly improved than those before IABP. At 30JACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/Cdays, 25 patients in the IABP group (28.7%) and 34 patients in the control
group (40.0%) had died (P<0.05). Secondary end points including the time to he-
modynamic stabilization, the length of stay in the intensive care unit, the duration of
catecholamine therapy, The IABP group were signiﬁcantly improved than control
group. There were no signiﬁcant differences between two groups with respect to the
rates of major bleeding (3.8%,4.4%, respectively; P¼0.52), peripheral ischemic
complications (2.8%,2.4%, P ¼ 0.53), sepsis (13.5%,14.7%,P¼0.18), and stroke
(0.8%,1.2%,P¼0.22).
Conclusions: The use of intraaortic balloon counterpulsation (IABP) could reduce
30-day mortality in patients with cardiogenic shock complicating acute myocardial
infarction, could not increase the complication of bleeding, ischemic complications,
sepsis, and stroke.
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The risk factors and the characteristics of coronary disease in young men with
acute myocardial infarction
Wang Junling
Department of Cardiology, No. 252 Hospital of PLA, Baoding, Hebei Province, China
Objectives: To observe the risk factors and the characteristics of coronary disease in
young men (45 years) with acute myocardial infarction (AMI).
Methods: The risk factors and coronary angiographic features were compared among
92 young men with acute myocardial infarction (among these patients, 70 cases with
ST segment elevation acute myocardial infarction (STEMI), 22 cases with Non-ST
segment elevation acute myocardial infarction (NSTEMI)), and 90 non-CHD young
men, 90 young women with AMI were included, all patients were admitted to hospital
from January 2009 to March 2014 and underwent coronary angiography. Smoking
history, familial history of early coronary heart disease (CHD), essential hypertension,
type 2 diabetes mellitus, hyperlipidemia, uric acid, lipids, total bilirubin, direct bili-
rubin, indirect bilirubin, white blood cells, red blood cells, hemoglobin were
measured. And observe the characteristics of coronary disease in young men with
AMI.
Results: (1) Prevalence of essential hypertension, Smoking history and familial his-
tory of early CHD were signiﬁcantly higher in young men with AMI than in age-
matched non-CHD control group (P<0.05). The levels of total cholesterol, very low
density lipoprotein, triglyceride were higher in young men with AMI, but had no
statistically signiﬁcant (P>0.05). (2) Prevalence of type 2 diabetes mellitus was
signiﬁcantly higher while smoking history and familial history of early CHD were
signiﬁcantly lower in young men with AMI than in young women; (3) Coronary
angiography revealed single-vessel disease in 63 cases (38 cases were anterior
descending branch, 17 cases were right coronary artery, 8 cases were left circumﬂex
left circumﬂex branch left circumﬂex branch branch), two-vessel disease in 17 cases
and multi-vessel disease in 10 cases.
Conclusions: Essential hypertension, Smoking history and familial history of early
CHD were the signiﬁcantly risk factors of AMI in young men. Single-vessel coronary
disease is the most common coronary angiographic features of young men with AMI,
and the most cases was the anterior descending branch.
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Association between the level of serum CEACAM-1 and coronary heart disease
Lu Si, Guoqing Wei, Rengyi Qian, Yujia Ye, Min Zhang, Zhaohui Meng
Laboratory of Molecular Cardiology, Department of Cardiology; The Firs Afﬁliated
Hospital Of Kunming Medical University
Objectives: The aim of the present study was to investigate the expression of
CEACAM-1 and MM-9 in patients with coronary heart disease so as to offer a better
new train of thought and basis for the diagnosis of coronary heart disease.
Methods: Serum samples were obtained from 133 patients with coronary artery
disease. All patients were hospitalized in the period from December 2012 to
October 2013 at the ﬁrst Afﬁliated Hospital of Kunming Medical University. the
patients having normal coronary arteries detected by coronary angiography were
included as a control group.According to clinical classiﬁcation, the patients were
divided into: stable angina, unstable angina, acute myocardial infaction and cor-
onary heart disease with type 2 diabetes; According to angiographic results, the
patients were divided into: single-vessel disease group, double vessel disease and
multivessel disease group; according to SYNTAX score, the patients were divided
into: 0w10, 10w20, 20w30 score and above 30 score; According to whether
active smoking, the patients were divided into active smoking and non-smoking;
According to the results of the CA coronary, the lesion vessels were divided
into collateral circulation group and no collateral circulation, collateral circula-
tion group on the basis of Rentrop grade, divided into a level 0, level 1, level 2,
level 3, and compared with normal group of CA,The protein expression levels of
CEACAM-1, MMP-9 were analyzed and compared by enzyme-linked immuno-
sorbent assay (ELISA).
Results:
1 AMI group compared with normal group, SAP group, the UAP group, the the
level of serum CEACAM1 in AMI group was clearly higher thanthe SAP
group, normal group and UAP group (p<0.05).
2 CHD+DM group compared with normal group, SAP group , UAP group, the
level of serum CEACAM1 of the CHD+DMI group was clearly higher thanthe
SAP group, normal group and UAP group (p<0.05).ardiovascular Disease Clinical Research C133
